Annual D&A
$1.56 M
-$195.00 K-11.09%
December 31, 2024
Summary
- As of March 8, 2025, RYTM annual depreciation & amortization is $1.56 million, with the most recent change of -$195.00 thousand (-11.09%) on December 31, 2024.
- During the last 3 years, RYTM annual D&A has risen by +$405.00 thousand (+34.97%).
- RYTM annual D&A is now -11.09% below its all-time high of $1.76 million, reached on December 31, 2023.
Performance
RYTM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$383.00 K
-$2000.00-0.52%
December 31, 2024
Summary
- As of March 8, 2025, RYTM quarterly depreciation & amortization is $383.00 thousand, with the most recent change of -$2000.00 (-0.52%) on December 31, 2024.
- Over the past year, RYTM quarterly D&A has dropped by -$2000.00 (-0.52%).
- RYTM quarterly D&A is now -16.19% below its all-time high of $457.00 thousand, reached on March 31, 2023.
Performance
RYTM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.56 M
-$34.00 K-2.13%
December 31, 2024
Summary
- As of March 8, 2025, RYTM TTM depreciation & amortization is $1.56 million, with the most recent change of -$34.00 thousand (-2.13%) on December 31, 2024.
- Over the past year, RYTM TTM D&A has dropped by -$34.00 thousand (-2.13%).
- RYTM TTM D&A is now -12.34% below its all-time high of $1.78 million, reached on June 30, 2023.
Performance
RYTM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
RYTM Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.1% | -0.5% | -2.1% |
| 3 y3 years | +35.0% | +17.9% | +35.0% |
| 5 y5 years | +87.4% | +17.9% | +35.0% |
RYTM Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | +35.0% | -16.2% | +17.9% | -12.3% | +35.0% |
| 5 y | 5-year | -11.1% | +126.5% | -16.2% | +129.3% | -12.3% | +126.5% |
| alltime | all time | -11.1% | -100.0% | -16.2% | +609.3% | -12.3% | +2794.4% |
Rhythm Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.56 M(-11.1%) | $383.00 K(-0.5%) | $1.56 M(-2.1%) |
| Sep 2024 | - | $385.00 K(-1.3%) | $1.60 M(-3.4%) |
| Jun 2024 | - | $390.00 K(-3.7%) | $1.65 M(-3.0%) |
| Mar 2024 | - | $405.00 K(-2.9%) | $1.71 M(-3.0%) |
| Dec 2023 | $1.76 M(+5.1%) | $417.00 K(-5.7%) | $1.76 M(-1.4%) |
| Sep 2023 | - | $442.00 K(0.0%) | $1.78 M(0.0%) |
| Jun 2023 | - | $442.00 K(-3.3%) | $1.78 M(+0.2%) |
| Mar 2023 | - | $457.00 K(+3.4%) | $1.78 M(+6.4%) |
| Dec 2022 | $1.67 M(+44.4%) | $442.00 K(0.0%) | $1.67 M(+7.5%) |
| Sep 2022 | - | $442.00 K(+0.9%) | $1.55 M(+8.9%) |
| Jun 2022 | - | $438.00 K(+25.1%) | $1.43 M(+9.3%) |
| Mar 2022 | - | $350.00 K(+7.7%) | $1.31 M(+12.9%) |
| Dec 2021 | $1.16 M(+67.8%) | $325.00 K(+3.2%) | $1.16 M(+14.5%) |
| Sep 2021 | - | $315.00 K(-0.6%) | $1.01 M(+16.5%) |
| Jun 2021 | - | $317.00 K(+57.7%) | $868.00 K(+19.9%) |
| Mar 2021 | - | $201.00 K(+12.9%) | $724.00 K(+4.9%) |
| Dec 2020 | $690.00 K | $178.00 K(+3.5%) | $690.00 K(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $172.00 K(-0.6%) | $703.00 K(-2.6%) |
| Jun 2020 | - | $173.00 K(+3.6%) | $722.00 K(-4.5%) |
| Mar 2020 | - | $167.00 K(-12.6%) | $756.00 K(-9.4%) |
| Dec 2019 | $834.00 K(+88.7%) | $191.00 K(0.0%) | $834.00 K(-2.7%) |
| Sep 2019 | - | $191.00 K(-7.7%) | $857.00 K(+11.0%) |
| Jun 2019 | - | $207.00 K(-15.5%) | $772.00 K(+23.3%) |
| Mar 2019 | - | $245.00 K(+14.5%) | $626.00 K(+41.6%) |
| Dec 2018 | $442.00 K(+98.2%) | $214.00 K(+101.9%) | $442.00 K(+53.5%) |
| Sep 2018 | - | $106.00 K(+73.8%) | $288.00 K(+21.5%) |
| Jun 2018 | - | $61.00 K(0.0%) | $237.00 K(+3.0%) |
| Mar 2018 | - | $61.00 K(+1.7%) | $230.00 K(+3.1%) |
| Dec 2017 | $223.00 K(+54.9%) | $60.00 K(+9.1%) | $223.00 K(+36.8%) |
| Sep 2017 | - | $55.00 K(+1.9%) | $163.00 K(+50.9%) |
| Jun 2017 | - | $54.00 K(0.0%) | $108.00 K(+100.0%) |
| Mar 2017 | - | $54.00 K | $54.00 K |
| Dec 2016 | $144.00 K(>+9900.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual D&A year-on-year change?
- What is Rhythm Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?
- What is Rhythm Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM D&A year-on-year change?
What is Rhythm Pharmaceuticals annual depreciation & amortization?
The current annual D&A of RYTM is $1.56 M
What is the all time high annual D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual depreciation & amortization is $1.76 M
What is Rhythm Pharmaceuticals annual D&A year-on-year change?
Over the past year, RYTM annual depreciation & amortization has changed by -$195.00 K (-11.09%)
What is Rhythm Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of RYTM is $383.00 K
What is the all time high quarterly D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly depreciation & amortization is $457.00 K
What is Rhythm Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, RYTM quarterly depreciation & amortization has changed by -$2000.00 (-0.52%)
What is Rhythm Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of RYTM is $1.56 M
What is the all time high TTM D&A for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM depreciation & amortization is $1.78 M
What is Rhythm Pharmaceuticals TTM D&A year-on-year change?
Over the past year, RYTM TTM depreciation & amortization has changed by -$34.00 K (-2.13%)